Wales or Scotland and aged under 15 years at the time of diagnosis with a malignant neoplasm at any site or any brain tumour. The principal sources of ascertainment are the National Cancer Registration schemes which cover the whole of Britain through a network of regional registries, the register of children under the care of members of the United Kingdom Children's Cancer Study Group (UKCCSG), local population-based childhood cancer registries in several regions, death certificates and entrants to the Medical Research Council (MRC) leukaemia trials. At the time of the present analysis the NRCT was complete up to 1995. It is the best centralized source of data on childhood cancer in Britain (Stiller et al, 1995) .
For comparison with cancers observed, expected numbers were calculated for sex, age group (0-4, 5-9 and 10-14 years) and 12 diagnostic groups of childhood malignancy by applying NRCT incidence rates for Britain to the live twin births. We corrected only for infant mortality because there were so few older deaths. Few details of emigration were known, so we estimated the maximum number of twins who had emigrated by record linking the cohort to the NHSCR to identify those definitely alive and in this country in 1991 (Gill et al, 1993) .
We systematically reviewed the published literature to identify studies providing risk estimates of childhood cancer incidence or mortality in twins. Results for incidence and mortality were separately pooled using a fixed effects model and weighting the result for each study by the inverse of its variance.
RESULTS
We identified 13 009 twins born 1963-1989 on the ORLS files and believe the cohort to be almost complete. Linkage to NHSCR suggested that emigration would have affected expected values by at most 5%, and probably considerably less.
Fifteen definite childhood malignancies were registered before 31 December 1995. Thirteen twin pairs were discordant for cancer, and one pair concordant for lymphoid leukaemia. Their birth order distribution was unremarkable. Three were three astrocytomas in females and three leukaemias in males. Table 2 shows that by age 15 about 18.9 cancers were expected compared to 15 observed producing a non significant standardized incidence ratio of 79 with a 95% Confidence Interval (CI) of 39-120. The concentration of observed and expected numbers at lower ages is explained by the age distribution of childhood cancer and by the fact that more recent birth cohorts had not yet reached the older age groups by 1995. For both sexes combined there were fewer cancers than expected in every age group. No value observed in any age group differed significantly from that expected. No important differences were observed in the ratio of observed to expected cancers according to the sex combination of twin pairs in the cohort (12 versus 12.83 in like-sex pairs and three versus 5.88 in unlike-sex pairs).
Birthweight was available for only 9022 babies in the cohort, largely because administrative procedures varied over time. Bias is therefore unlikely but the birthweight of twins is considerably lower on average than for singletons. Examination of observed versus expected cancers by birthweight groups indicated nonsignificant incidence deficits below 3000 g (and among the group with unknown birthweight) and an excess in those weighing 3000 g or above (data not shown). Table 3 shows the results of the five previous prospective studies of cancer occurrence in twins (and our own). Of six heavily overlapping studies of childhood cancer from Sweden, (Forsberg and Källen, 1990; Zack et al, 1991; Cnattingius et al, 1995; Linet et al, 1996; Mogren et al, 1999; Rodvall et al, 1992) , only one (Rodvall et al, 1992 ) reported a numerical risk for all childhood cancers in twins, that could therefore be included in a pooled analysis. Only one retrospective case-control study was identified (Savitz and Ananth, 1994) reporting a non-significantly increased odds ratio 1.5 (0.4-5.0). Its inclusion does not affect the results of pooled analysis and we have excluded it because of its design. Fewer cancers were observed than expected in every study, whether considering incidence or mortality and in almost every case when subdividing available data into the leukaemias and all other cancers. Pooled analysis of the four studies presenting incidence data produced a significantly low total cancer standardized incidence ratio of 81 with 95% CI (67-96). Pooling of the three mortality studies also produced a significantly low standardized mortality ratio for all cancers of 85 with 95% CI (74-95). In neither instance was there any evidence of significant heterogeneity.
DISCUSSION
ORLS twins experienced some 20% fewer childhood cancers than expected. Our cohort had the advantages of lack of selection, a population base, and information on individual mortality and aggregate migration. By linkage to the NRCT with excellent identifiers both observed and expected numbers of incident cancers, though small, are likely to be accurate. In our study the higher still birth rate and infant mortality of twins was also seen in the first few years of childhood, as described by others (e.g. Rodvall et al, 1992) though at much lower absolute rates than in infancy.
The ORLS deficit of twin childhood cancer agrees with the findings of other cohort studies (Hewitt et al, 1966; Jackson et al, 1969; Norris and Jackson, 1970; Windham et al, 1985; Inskip et al, 1991; Rodvall et al, 1992) . Our study is most comparable to that of Windham et al in terms of size and the period of twin birth (Windham et al, 1985) . Both cohorts would have been less exposed to prenatal X-rays than the older studies, because of alternative obstetric methods of confirming twins, assessing fetal growth and imaging the fetal position. A review of previous studies commented that although there were no significant differences in cancer incidence between twins and singletons in any one of the studies, the aggregate data (including their own) pointed to a slightly lower risk amongst twins (Inskip et al, 1991) . Pooling the data reviewed by Inskip et al (Inskip et al, 1991) , the subsequent data of Rodvall et al (Rodvall et al, 1992) and our own indicates a significant deficit of 15-20% in incident and fatal cancers of all types. Only the Connecticut study (Inskip et al, 1991) reported childhood cancer incidence by sex of the co-twin, though another study (Swerdlow et al, 1996) reported detailed data for childhood and young adulthood combined. As here, neither found any strong evidence that risk of all cancers was influenced by sex combination of the twin pair, or birth order. No prospective study has found an overall excess, despite differences in study size, design, population and outcome and it seems difficult to conclude that this consistent finding of a deficit could be due to methodological artefact. The tendency to lower birthweight of twins (perhaps because of fewer cell divisions or altered growth factor exposure) and the selection effects of high stillbirth and death rates in infancy may be relevant (Forsberg and Kallen, 1990; McKinney et al, 1999; Ross et al, 1996; Roman et al, 1997) . Our birthweight data provide some slight support for the former hypothesis. Another possibility may be prenatal loss of potentially concordant pairs (Hewitt et al, 1966) . There is increasing recognition that the scale on which twins 'vanish' and are delivered as a singleton pregnancy may be considerable. Further studies incorporating additional clinical information, may explain the emerging finding of decreased childhood cancer incidence in twins.
